Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Onconova Therapeutics Inc. (ONTX)

0.28   0.004 (1.49%) 10-01 09:07
Open: 0.2721 Pre. Close: 0.2759
High: 0.28 Low: 0.265
Volume: 5,292,281 Market Cap: 51M
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. The company is headquartered in Newtown, Pennsylvania and currently employs 25 full-time employees. The firm operates through the identification and development of oncology therapeutics segment. The company is focused on discovering and developing small molecule drug candidates to treat cancer. The firm has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. The company has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The firm's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.28 - 0.283 0.283 - 0.284
Low: 0.265 - 0.268 0.268 - 0.269
Close: 0.277 - 0.281 0.281 - 0.283

Technical analysis

as of: 2020-09-30 4:44:56 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.40     One year: 0.51
Support: Support1: 0.19    Support2: 0.16
Resistance: Resistance1: 0.34    Resistance2: 0.44
Pivot: 0.27
Moving Average: MA(5): 0.28     MA(20): 0.26
MA(100): 0.60     MA(250): 0.50
MACD: MACD(12,26): -0.08     Signal(9): -0.11
Stochastic oscillator: %K(14,3): 34.36     %D(3): 37.38
RSI: RSI(14): 38.00
52-week: High: 1.56  Low: 0.10  Change(%): -65.6
Average Vol(K): 3-Month: 2345122  10-Days: 3495118

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ONTX has closed below upper band by 45.1%. Bollinger Bands are 62.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to ONTX's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 29 Sep 2020
The Forecast Just Changed on Onconova Therapeutics Inc. (NASDAQ:ONTX) - The Oracle Dispatch

Mon, 28 Sep 2020
Roll up the Sleeves! When the bell rang at previous close Onconova Therapeutics Inc. (ONTX) was down -3.69% - The InvestChronicle

Mon, 21 Sep 2020
Onconova Therapeutics Announces Initiation of a Phase 1 Clinical Trial of ON 123300 in China by Partner HanX Biopharmaceuticals - GlobeNewswire

Fri, 18 Sep 2020
Onconova Therapeutics Inc (ONTX) Stock: What Does the Chart Say? - InvestorsObserver

Fri, 18 Sep 2020
Onconova Therapeutics, Inc. (ONTX) Stock Behavior Isn’t As Predictable As You Think - Stocks Register

Thu, 17 Sep 2020
Onconova Therapeutics Inc. (ONTX) Open at price of $0.232: A Brand-New Opportunity for Investors - News Daemon

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 184
Shares Float (M) 179
% Held by Insiders 0.91
% Held by Institutions 11.16
Shares Short (K) 10,560
Shares Short P. Month (K) 11,490

Stock Financials

EPS -0.243
EPS Est This Year -2.860
EPS Est Next Year -2.100
Book Value (p.s.) 0.090
Profit Margin
Operating Margin -11587.07
Return on Assets (ttm) -79.2
Return on Equity (ttm) -411.8
Qtrly Rev. Growth -97.2
Gross Profit (p.s.) 0.012
Sales Per Share 0.001
EBITDA (p.s.) -0.127
Qtrly Earnings Growth
Operating Cash Flow (M) -21
Levered Free Cash Flow (M) -12

Stock Valuations

PE Ratio -1.15
PEG Ratio
Price to Book value 3.09
Price to Sales 254.27
Price to Cash Flow -2.42

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.